Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-26-018626·Braeden Lichti
Schedule 13D ownership disclosure
ENVVENO MEDICAL CORPORATION
Common Stock, par value $0.00001 per share · CUSIP: 29415J205
Event date: 2026-02-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Braeden LichtiReported CIK 0001982476
Shares: 33,151.00 · Class: 5.05%
- Northstrive Fund II LPReported CIK 0002099270
Shares: 20,129.00 · Class: 3.07%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-018626
- Form type
- SCHEDULE 13D
- Filer
- Braeden Lichti
- CIK
- CIK 1982476
- Filed
- Feb 20, 2026
- Reporting period
- Feb 20, 2026
- Description
- Schedule 13D beneficial ownership